ERBB2 and neoplasm: In summary, Her-2 overexpression can increase tumor malignancy by promoting infiltration, lymph node metastasis, and neurovascular invasion, increasing the level of signet ring cell carcinoma component and MMR instability, and decreasing the degree of organization differentiation, which leads to an undesirable survival outcome.